Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Polyurethane Male Condoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Between the ages of 18 and 45 (inclusive)~2. Protected against pregnancy by oral contraceptives, an IUD, an implant, contraceptive injections, contraceptive patch, or sterilization (tubal ligation or vasectomy)~3. Have home internet access, a valid personal email for each partner, ability to videoconference and use electronic signature technology~4. Willing and able to give electronic informed consent~5. Willing to respond to questions concerning their reproductive and contraceptive history and use of condoms via interview or self-administered questionnaires~6. Have vaginal intercourse at least once weekly~7. Willing to use the study products for fifteen acts of vaginal intercourse within nine weeks of study entry~8. In a mutually exclusive monogamous relationship with their study partner for at least 6 months and be willing to remain mutually monogamous throughout study participation~9. Both study partners have previous experience using male condoms~10. Agree not to use any additional vaginal or sexual lubricant except the AstroglideTM product provided, if desired, supplied by the study~11. Agree not to expose the study condoms to jewelry (hand, facial, or genital) or piercings (facial or genital) that could damage the study condoms.~12. Agree not to use sex toys or drugs intended to enhance or diminish sexual response when using study condoms~13. Male partner agrees to ejaculate during vaginal intercourse~14. Agree to (or partner) hold the condom at the base of the erect penis during withdrawal~15. Agree to return any condoms that break during use~16. Agree to return any unopened condoms~17. Reachable by telephone~Exclusion Criteria:~1. Currently participating in another similar clinical study~2. Female partner self-reported as pregnant~3. Allergic to natural rubber latex or polyurethane, or has a history of recurrent adverse events following use of latex or polyurethane products~4. Unable to follow study requirements, use instructions or attend study visits or exchanges~5. Have a significant (high) risk of STIs, including HIV infection, or having a medical history of recurrent, uncontrolled STIs (e.g. gonorrhoea, syphilis, Chlamydia, etc.)~6. Currently using condoms for protection against a known STI~7. Taking any internally applied medication to treat a genital condition that could interact with the study condom~8. Male partner has used medication that has caused erectile dysfunction, or had difficulty achieving/maintaining an erection, or achieving ejaculation in the last month under typical circumstances/conditions~9. Male has had a prostatectomy~10. Any self-reported genitourinary condition (e.g. itching, burning, irritation, etc.) which, in the opinion of the investigator, could affect use of the study condoms or the ability to interpret study data~11. Employee or affiliate of Essential Access Health or Sagami Rubber Industries Co., Ltd.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Control Latex Condom C (Type: ACTIVE_COMPARATOR): Commercial Natural Rubber Latex Male Condom
- Polyurethane Condom A (Type: EXPERIMENTAL): Polyurethane Condom A (002)
- Polyurethane Condom B (Type: EXPERIMENTAL): Polyurethane Condom B (001)

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete